Keywords
Treatment
Long-term effects
How to Cite
Abstract
The article addresses the importance of pediatric oncology, highlighting recent advances in childhood cancer treatment, such as immunotherapy and early diagnosis, which have improved survival rates. However, it underscores the significant challenges faced by survivors, including physical complications like cardiovascular diseases, pulmonary dysfunctions, and endocrine problems, as well as reproductive, cognitive, and musculoskeletal issues. The mental and psychological health of these individuals is also discussed, with high rates of anxiety disorders, depression, and PTSD among survivors, exacerbated by socioeconomic challenges. The article emphasizes the need for a holistic approach in the care of these patients, including psychological support, physical rehabilitation, and socioeconomic guidance, along with long-term follow-up programs to manage the adverse effects of treatment. The conclusion highlights the importance of investing in continuous research and comprehensive support programs to improve the quality of life of survivors, promoting an integrated and multidisciplinary approach to meet their complex and diverse needs.
References
Smith J, et al. Advances in Pediatric Oncology: Immunotherapy. J Pediatr Hematol Oncol. 2021;19(6):755-765. DOI: 10.1097/MPH.0000000000002121.
Jones A, et al. Early Diagnosis in Pediatric Cancer: Importance and Impact. Hum Reprod. 2021;36(1):16-24. DOI: 10.1093/humrep/deaa256.
Williams R, et al. Psychological Support in Pediatric Oncology. Br J Haematol. 2020;157(7):839-848. DOI: 10.1111/bjh.15775.
Brown L, et al. Nutrition and Pediatric Cancer Treatment. J Clin Oncol. 2020;38(4):322-332. DOI: 10.1200/CCI.18.00015.
Taylor D, et al. Long-Term Effects of Pediatric Cancer Treatment. Pediatr Blood Cancer. 2019;66(4):e27548. DOI: 10.1002/pbc.27548.
Miller H, et al. Technological Innovations in Pediatric Oncology. BMC Pediatr. 2020;20(1):445. DOI: 10.1186/s12887-020-02355-2.
Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Pediatric Blood & Cancer. 2021;68(4). DOI: 10.1002/pbc.28783.
Anderson RA, Wallace WHB. Fertility preservation in childhood cancer. Human Reproduction. 2021;36(1):16-24. DOI: 10.1093/humrep/deaa287.
Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371-2381. DOI: 10.1001/jama.2013.6294.
Chemaitilly W, Cohen LE. Endocrine late effects of childhood cancer treatment: scope of the problem and recommendations for care. Nature Reviews Endocrinology. 2021;17:199-212. DOI: 10.1038/s41574-020-00451-3.
Michel G, von der Weid NX, Zwahlen M, et al. The Swiss Childhood Cancer Survivor Study: challenges of follow-up studies in a national cohort. Swiss Med Wkly. 2024;154. DOI: 10.4414/smw.2024.13956.
Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2021;290(12):1583-1592. DOI: 10.1001/jama.290.12.1583.
Smith WA, Li C, Nottage KA, et al. Lifestyle and health behaviors of adult childhood cancer survivors: a report from the St. Jude Lifetime Cohort Study. JAMA. 2021;305(1):34-41. DOI: 10.1001/jama.2010.1974.
Melissa A. Frick et al., Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma. JCO Clin Cancer Inform 2, 1-10(2018). DOI:10.1200/CCI.18.00015
Francesco Pallotti, Marianna Pelloni, Fabiana Faja, Silvia Di Chiano, Alice Di Rocco, Andrea Lenzi, Francesco Lombardo, Donatella Paoli, Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study, Human Reproduction, Volume 36, Issue 1, January 2021, Pages 16–25, https://doi.org/10.1093/humrep/deaa266
Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2018 Dec;19(12):1590-1601. doi: 10.1016/S1470-2045(18)30537-0. Epub 2018 Nov 8. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10. doi: 10.1016/S1470-2045(18)30928-8. PMID: 30416076; PMCID: PMC6309183.
Bozkurt, S., Genc, D. & Vural, S. Laboratory and clinical features of tumor lysis syndrome in children with non-Hodgkin lymphoma and evaluation of long-term renal functions in survivors. BMC Pediatr 24, 85 (2024). https://doi.org/10.1186/s12887-024-04549-w
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Leticia Pace, Marina Santin Cavalcante, Camille Giordana Riva, Julia Borges Barbero, Anthonielly Leinat Lima, Larissa Paula Pinho Simão, João Vitor Silva de Moraes Almeida, Aaron Vicentin, Gabriela Barroso Miranda, THEODORO AUGUSTO BICALHO DE ALENCAR MINUZZI CAPELETTI, Bárbara Luchetta Garcia, Karine Negrisoli de Souza